Home » Human Microbiome Market
Human Microbiome Market
Published date: Nov 2021 •Formats:
Request Sample Schedule a Call

Global Human Microbiome Market By Type (Gastrointestinal Tract Human Micobiome, and Urogenital Tract Human Micobiome), By Application (Treatment, and Diagnosis), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • Published date: Nov 2021
  • Report ID: 21467
  • Number of Pages: 279
  • Format:
  • keyboard_arrow_up
    • 1. Human Microbiome Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Human Microbiome Market Overview
      • 3.1. Human Microbiome Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Human Microbiome Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Human Microbiome Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Gastrointestinal Tract Human Micobiome
      • 4.4. Urogenital Tract Human Micobiome
    • 5. Global Human Microbiome Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Human Microbiome Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Treatment
      • 5.4. Diagnosis
    • 6. Global Human Microbiome Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Human Microbiome Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Human Microbiome Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Human Microbiome Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Human Microbiome Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Human Microbiome Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Human Microbiome Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Vedanta
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Seres Therapeutics
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Second Genome
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Rebiotix
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. ActoGeniX
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Enterome BioScience
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. AvidBiotics
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10.4D Pharma Research Ltd
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. Enterologics
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Metabogen
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
      • 7.13. Metabiomics
        • 7.13.1. Company Overview
        • 7.13.2. Financial Highlights
        • 7.13.3. Product Portfolio
        • 7.13.4. SWOT Analysis
        • 7.13.5. Key Strategies and Developments
      • 7.14. Ritter Pharmaceuticals
        • 7.14.1. Company Overview
        • 7.14.2. Financial Highlights
        • 7.14.3. Product Portfolio
        • 7.14.4. SWOT Analysis
        • 7.14.5. Key Strategies and Developments
      • 7.15. Osel
        • 7.15.1. Company Overview
        • 7.15.2. Financial Highlights
        • 7.15.3. Product Portfolio
        • 7.15.4. SWOT Analysis
        • 7.15.5. Key Strategies and Developments
      • 7.16. Symberix
        • 7.16.1. Company Overview
        • 7.16.2. Financial Highlights
        • 7.16.3. Product Portfolio
        • 7.16.4. SWOT Analysis
        • 7.16.5. Key Strategies and Developments
      • 7.17. Miomics
        • 7.17.1. Company Overview
        • 7.17.2. Financial Highlights
        • 7.17.3. Product Portfolio
        • 7.17.4. SWOT Analysis
        • 7.17.5. Key Strategies and Developments
      • 7.18. Symbiotix Biotherapies
        • 7.18.1. Company Overview
        • 7.18.2. Financial Highlights
        • 7.18.3. Product Portfolio
        • 7.18.4. SWOT Analysis
        • 7.18.5. Key Strategies and Developments
      • 7.19. MicroBiome Therapeutics LLC
        • 7.19.1. Company Overview
        • 7.19.2. Financial Highlights
        • 7.19.3. Product Portfolio
        • 7.19.4. SWOT Analysis
        • 7.19.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
    • Vedanta
    • Seres Therapeutics
    • Second Genome
    • Rebiotix
    • ActoGeniX
    • Enterome BioScience
    • AvidBiotics
    • 4D Pharma Research Ltd
    • Enterologics
    • Metabogen
    • Metabiomics
    • Ritter Pharmaceuticals
    • Osel
    • Symberix
    • Miomics
    • Symbiotix Biotherapies
    • MicroBiome Therapeutics LLC
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Human Microbiome Market
  • 21467
  • Nov 2021
    • ★★★★★
      ★★★★★
    • (47)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore